Health Care [ 9/12 ] | Health Care Equipment & Supplies [ 61/73 ]
NASDAQ | Common Stock
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.
The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration.
It also develops NELL-1/DBM fusion device used in lumbar spinal fusion.
The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine.
The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications.
Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 12, 25 | -0.32 Increased by +75.61% | -7.68 Increased by +95.84% |
| Feb 19, 25 | -0.48 Increased by +80.57% | -0.65 Increased by +26.15% |
| Nov 12, 24 | -2.37 Decreased by -288.52% | -0.60 Decreased by -295.00% |
| Aug 9, 24 | -0.67 Decreased by -39.58% | -1.39 Increased by +51.80% |
| May 14, 24 | -1.31 Increased by +81.01% | -7.60 Increased by +82.76% |
| Feb 20, 24 | -2.47 Decreased by -1.27 K% | -5.60 Increased by +55.89% |
| Nov 14, 23 | -0.61 Decreased by -408.33% | -3.04 Increased by +79.93% |
| Aug 14, 23 | -0.48 Decreased by -860.00% | -1.50 Increased by +68.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 0.00 Decreased by N/A% | -1.02 M Decreased by -17.44% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -1.52 M Increased by +1.81% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -941.00 K Increased by +50.99% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -784.00 K Increased by +55.68% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -866.00 K Increased by +76.66% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -1.55 M Decreased by -273.48% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.92 M Decreased by -57.51% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -1.77 M Decreased by -277.19% | Decreased by N/A% Decreased by N/A% |